Monopar Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-0.609; its P/E ratio is -1.12; Monopar Therapeutics Inc is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -2.07M	$ -2.33M	$ -2.49M	$ -2.94M	$ -2.41M
EBITDA	$ -2.07M	$ -2.33M	$ -2.49M	$ -2.94M	$ -2.41M
Net Income Common Stockholders	$ -1.95M	$ -2.20M	$ -2.40M	$ -2.93M	$ -2.40M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.52M	$ 7.21M	$ 5.73M	$ 8.19M	$ 14.32M
Total Assets	$ 8.59M	$ 10.34M	$ 11.83M	$ 13.23M	$ 14.45M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 8.41K	$ 20.85K
Net Debt	$ -5.52M	$ -7.21M	$ -5.73M	$ -8.18M	$ -14.30M
Total Liabilities	$ 1.98M	$ 2.50M	$ 2.89M	$ 3.14M	$ 1.94M
Stockholders Equity	$ 6.61M	$ 7.84M	$ 8.94M	$ 10.09M	$ 12.51M
Cash Flow	-
Free Cash Flow	$ -1.94M	$ -2.10M	$ -2.27M	$ -1.30M	$ -2.15M
Operating Cash Flow	$ -1.94M	$ -2.10M	$ -2.27M	$ -1.30M	$ -2.15M
Investing Cash Flow	$ -13.05K	$ 2.95M	$ -983.44K	$ -4.92M	-
Financing Cash Flow	$ 246.70K	$ 641.18K	$ 804.80K	$ 138.74K	$ -23.74K

Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

Income Statement >

Monopar Therapeutics Inc Debt to Assets

Balance Sheet >

Monopar Therapeutics Inc Cash Flow

Cash Flow >

Monopar Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing